Bayer has convinced jurors it bears no liability for patient cancers in a jury trial held in St. Louis, according to several media outlets.
The verdict is notable for two reasons: it's the fifth consecutive such jury trial the chemical manufacturer has one involving Roundup and its active ingredient, glyphosate, and the first such trial involving multiple defendants.
Hundreds of lawsuits involving non-Hodgkins lymphoma, a disease without a defined medical cause, and roundup remain pending in various courts.
The lawsuits have in the past been filed against Missouri-headquartered Monsanto, which Bayer acquired in 2018.
The Supreme Court petition was one of the pillars of a five-point plan Bayer announced in May 2021 to deal with the Roundup litigation. The plan also included beginning to remove glyphosate from Roundup sold to American residential consumers. Most of the Roundup cases involve such users.
Under Bayer’s plan, Roundup sold to commercial users will still include glyphosate. Commercial users account for the bulk of Roundup’s sales.
The St. Louis trial involved three plaintiffs older than 60 who claimed the company was responsible for warning them about the cancer as a potential side effect.